Press Releases

Keymed Biosciences today announced the National Medical Products Administration of China has recently approved the supplemental New Drug Application (the "sNDA") of Stapokibart (anti-IL-4Rα monoclonal antibody, trade name: Kangyueda, for the treatment of seasonal allergic rhinitis. The approval is based on a multi-center, randomized, double-blind, placebo-controlled phase III study to confirm the efficacy and safety of Stapokibart injection in treatment of adult pati

Medical Oncology Associates of San Diego (MOASD), a leading Southern California independent oncology practice, is proud to announce the opening of its fifth cancer care center in San Diego County. The  La Jolla clinic, in partnership with esteemed oncologist and hematologist Sabina Wallach, MD, expands the practice's reach and enhances its ability to deliver high-quality cancer care throughout San Diego County. Dr. Wallach is joined at the La Jolla center by a dedicated tea

NimVax, the nation's first vaccine-only pharmacy, is disrupting the pharmacy marketplace and redefining how pharmacies should be with the addition of a Medication Dispensing Service, NimMed. NimVax opened its doors to the public in 2021 as a vaccine-only pharmacy delivering vaccines including COVID-19, Influenza, RSV, Hepatitis B, Shingles, Pneumococcal, and Td/Tdap. The pharmacy quickly gained a reputation for its friendly, professional service, immaculate ambiance, and spa-lik

The Healthcare Information and Management Systems Society (HIMSS) and the Association of Medical Directors of Information Systems (AMDIS) today announced the signing of an exclusive partnership agreement to create a permanent link between their global networks of health professionals. The partnership will grow and enhance the educational programming and resources available to physicians and clinical leaders. After decades of collaboration, the expanded partnership aims to leverage t

Velico, Inc. has launched a groundbreaking collaboration with the South Texas Blood and Tissue Center (STB&T), a subsidiary of San Antonio-based non-profit BioBridge Global and a recognized leader in prehospital transfusion. STB&T has made history as the first U.S. civilian blood center to install Velico's FrontlineODP™ system for spray drying human plasma as part of Velico's Blood Center Education Program (BCEP). Through its participation in BCEP, STB&T ga

ScribeAI, an innovative healthcare technology company, today announced its official launch out of stealth mode. By leveraging artificial intelligence (AI) to transform clinician-patient interactions into SOAP notes, ScribeAI reduces documentation time by up to 90%, giving healthcare professionals more time to focus on patient care. For healthcare systems, adopting ScribeAI delivers significant benefits, including enhanced provider efficiency and return on investment in some cases exceeding 1,

Ryght AI, a leading provider of real-time generative AI solutions for the clinical research industry, and Cancer Research South Australia (CRSA), a premier cancer care provider, have announced a strategic partnership to advance cancer clinical trials in South Australia. Through this collaboration, CRSA will join the Ryght Research Network, leveraging Ryght AI's cutting-edge technology to optimize and accelerate clinical trials for people with cancer. This collaboration marks a s

GE HealthCare today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the updated portfolio of Voluson™ Expert Series ultrasound systems. Voluson Expert 22, 20 and 18 combine high resolution image quality with advanced ultrasound technology and an ergonomic design for efficient workflow and a world-class user experience. The Voluson Expert Series integrates artificial intelligence (AI)-powered features and automation tools to help d

PureHealth Holding PJSC, the largest healthcare group in the Middle East, has agreed to acquire a 60% stake in Hellenic Healthcare Group (HHG), the largest private healthcare provider in Greece and Cyprus, in a transaction that values HHG at USD 2.3 billion. HHG is currently owned 90% by CVC Capital Partners VI and 10% by the founder of HHG. PureHealth will acquire a 60% stake in HHG, with CVC Capital Partners retaining 35% ownership, while the remaining 5% stake in the company is held by the

Advanced Instruments, the leading supplier in osmolality testing, announces the newest update to its clinical line of freezing point osmometers. The OsmoPRO® MAX is designed for clinical laboratories of all sizes seeking enhanced productivity through automation. The instrument uses innovative flow-through technology to eliminate manual pipetting and reduce the use of consumables, allowing testing to begin with the single push of a button. The OsmoPRO MAX goes beyond pr